SpecialeAnalysis

Biogen testing channel support

NASDAQ:BIIB   Biogen Inc.
Biogen Inc. (BIIB) currently testing channel support, able to absorb weekly selling pressures.

From here, (BIIB) can recover and turn higher to channel resistance, eliciting gains of 20-25% over the following 2 - 3 months.

A settlement above this week’s high would accelerate this upward momentum.

Inversely, closing below this channel support would indicate losses of 20% over the following 2 - 3 months where (BIIB) can bottom out into Q4.

Anthony Speciale, founder of Speciale Analysis offers an affordable approach for all traders to grow into their highest potential.
면책사항

이 정보와 게시물은 TradingView에서 제공하거나 보증하는 금융, 투자, 거래 또는 기타 유형의 조언이나 권고 사항을 의미하거나 구성하지 않습니다. 자세한 내용은 이용 약관을 참고하세요.